Global Lancets Market – Industry Analysis and Forecast (2019-2027) – by Type, by End Users, by Application and by Region

Global Lancets Market was valued at US$ 774.2 Mn in 2019 and is expected to reach US$ 1832.7 Mn by 2027, at a CAGR of 11.37 % during the forecast period. The report includes an analysis of the impact of COVID-19 lockdown on the revenue of market leaders, followers, and disruptors. Since the lockdown was implemented differently in various regions and countries; the impact of the same is also seen differently by regions and segments. The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region.

Global Lancets Market

To know about the Research Methodology:-Request Free Sample Report

Global Lancets Market Dynamics:

Lancets are being used for diabetes or glucose test, tests in infants, heel-stick screening tests, as well as for scarred emergency patients or harshly burned patients. The factors driving the market growth include increasing incidence rate of contagious and non-contagious diseases, growing prevalence of diabetes, and rising inclination towards home care and home diagnostics. However, the risk associated with blood transfusion and poor reimbursement scenario in developing countries is expected to hamper the market growth during the forecast period.

Global Lancets Market Segment Analysis:

The hospitals and clinics segment accounted for the largest share of the lancets market in 2019. This segment is primarily attributed to the availability of a large patient pool and the growing prevalence of infectious diseases that require blood testing for diagnosis and treatment.

Global Lancets Market Regional Insights:

Region-wise, the North American market for Lancet is expected to grow at a CAGR of 11.2% during the forecasted period. This is because of the increasing prevalence of diabetic patients. Europe is the second-largest market for Lancet with a market value of US$ 732.2 Mn in 2019. Whereas the Asia Pacific is expected to lead the Lancet market and to grow at a rapid rate. A recent development in Global Lancets Market: In October 2017, Abbott Laboratories announced the USA Food & Drug Administration appreciation for Abbott's FreeStyle Libre Flash Glucose Monitoring System for adults. This product approval goals at enhancing the company’s products offering. In August 2017, HTL-STREFA S.A donated safety lancets to the GLOBAL-MED organization in Poland, which created an enterprise called ‘Ambulans z serca’ (Ambulance from the heart), to perform free glucose screenings during healthcare events. With this, the company goals to expand its customer base, so strengthening its presence in the market. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data, and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Lancets Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address the question of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in Global Lancets Market.

Global Lancets Market, Key Highlights:

• Global Lancets Market analysis and forecast, in terms of value. • Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Lancets Market • Global Lancets Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided. • Global Lancets Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study. • Global Lancets Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation. • Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled. • Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Lancets Market are also profiled.

Scope of the Global Lancets Market Report: Inquire before buying

Global Lancets Market, By Type

• Safety Lancets o Push-Button Lancets o Pressure-Activated Lancets o Side-Button Lancets • Personal Lancets

Global Lancets Market, By Application

• Glucose Testing • Hemoglobin Testing • Coagulation Testing • Other Applications

Global Lancets Market, By End User

• Hospitals & Clinics • Home Care Settings • Other End Users

Global Lancets Market, By Region

• North America • Europe • Asia Pacific • Middle East and Africa • South America

Key Players Operating in the Global Lancets Market :

• Becton, Dickinson and Company • Roche Diagnostics • Ypsomed • B. Braun Melsungen • Terumo Corporation • Owen Mumford • HTL-Strefa S.A • Arkray • Sarstedt • Sterilance Medical (Suzhou) • Medline Industries • Intrinsyk • I-SENS • Nipro • Omron • Infopia • Terumo Corporation • Bayer AG • Abbott Laboratories • F. Hoffmann-La Roche Ltd • Greiner Bio-One International GmbH • Improve Medical Instruments Co. Ltd • Lifescan • AgaMatrix • Smiths Medical • SANNUO • Yicheng • Yuwell • Edan • Narang Medical

Global Lancets Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Lancets Market Size, by Market Value (US$ Mn) and Volume (Units) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7.Industry Trends in Global Lancets Market 4.8. Global Lancets Market Competitive Landscape 5. Supply Side and Demand Side Indicators 6. Global Lancets Market Analysis and Forecast 6.1. Global Lancets Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Lancets Market Analysis and Forecast, by Application 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Lancets Market Value Share Analysis, by Application 7.4. Global Lancets Market Size (US$ Mn) Forecast, by Application 7.5. Global Lancets Market Analysis, by Application 7.6. Global Lancets Market Attractiveness Analysis, by Application 8. Global Lancets Market Analysis and Forecast, by End User 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Lancets Market Value Share Analysis, by End User 8.4. Global Lancets Market Size (US$ Mn) Forecast, by End User 8.5. Global Lancets Market Analysis, by End User 8.6. Global Lancets Market Attractiveness Analysis, by End User 9. Global Lancets Market Analysis and Forecast, by Type 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Lancets Market Value Share Analysis, by Type 9.4. Global Lancets Market Size (US$ Mn) Forecast, by Type 9.5. Global Lancets Market Analysis, by Type 9.6. Global Lancets Market Attractiveness Analysis, by Type 10. Global Lancets Market Analysis, by Region 10.1. Global Lancets Market Value Share Analysis, by Region 10.2. Global Lancets Market Size (US$ Mn) Forecast, by Region 10.3. Global Lancets Market Attractiveness Analysis, by Region 11. North America Lancets Market Analysis 11.1. Key Findings 11.2. North America Lancets Market Overview 11.3. North America Lancets Market Value Share Analysis, by Application 11.4. North America Lancets Market Forecast, by Application 11.4.1. Glucose Testing 11.4.2. Hemoglobin Testing 11.4.3. Coagulation Testing 11.4.4. Other Applications 11.5. North America Lancets Market Value Share Analysis, by End User 11.6. North America Lancets Market Forecast, by End User 11.6.1. Hospitals & Clinics 11.6.2. Home Care Settings 11.6.3. Other End Users 11.7. North America Lancets Market Value Share Analysis, by Type 11.8. North America Lancets Market Forecast, by Type 11.8.1. Safety Lancets 11.8.1.1. Push-Button Lancets 11.8.1.2. Pressure-Activated Lancets 11.8.1.3. Side-Button Lancets 11.8.2. Personal Lancets 11.9. North America Lancets Market Value Share Analysis, by Country 11.10. North America Lancets Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Lancets Market Analysis, by Country 11.12. U.S. Lancets Market Forecast, by Application 11.12.1. Glucose Testing 11.12.2. Hemoglobin Testing 11.12.3. Coagulation Testing 11.12.4. Other Applications 11.13. U.S. Lancets Market Forecast, by End User 11.13.1. Hospitals & Clinics 11.13.2. Home Care Settings 11.13.3. Other End Users 11.14. U.S. Lancets Market Forecast, by Type 11.14.1. <200 HP 11.14.2. 200-300 HP 11.14.3. >300 HP 11.15. Canada Lancets Market Forecast, by Application 11.15.1. Glucose Testing 11.15.2. Hemoglobin Testing 11.15.3. Coagulation Testing 11.15.4. Other Applications 11.16. Canada Lancets Market Forecast, by End User 11.16.1. Hospitals & Clinics 11.16.2. Home Care Settings 11.16.3. Other End Users 11.17. Canada Lancets Market Forecast, by Type 11.17.1. Safety Lancets 11.17.1.1. Push-Button Lancets 11.17.1.2. Pressure-Activated Lancets 11.17.1.3. Side-Button Lancets 11.17.2. Personal Lancets 11.18. North America Lancets Market Attractiveness Analysis 11.18.1. By Application 11.18.2. By End User 11.18.3. By Type 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Lancets Market Analysis 12.1. Key Findings 12.2. Europe Lancets Market Overview 12.3. Europe Lancets Market Value Share Analysis, by Application 12.4. Europe Lancets Market Forecast, by Application 12.4.1. Glucose Testing 12.4.2. Hemoglobin Testing 12.4.3. Coagulation Testing 12.4.4. Other Applications 12.5. Europe Lancets Market Value Share Analysis, by End User 12.6. Europe Lancets Market Forecast, by End User 12.6.1. Hospitals & Clinics 12.6.2. Home Care Settings 12.6.3. Other End Users 12.7. Europe Lancets Market Value Share Analysis, by Type 12.8. Europe Lancets Market Forecast, by Type 12.8.1. Safety Lancets 12.8.1.1. Push-Button Lancets 12.8.1.2. Pressure-Activated Lancets 12.8.1.3. Side-Button Lancets 12.8.2. Personal Lancets 12.9. Europe Lancets Market Value Share Analysis, by Country 12.10. Europe Lancets Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Lancets Market Analysis, by Country 12.12. Germany Lancets Market Forecast, by Application 12.12.1. Glucose Testing 12.12.2. Hemoglobin Testing 12.12.3. Coagulation Testing 12.12.4. Other Applications 12.13. Germany Lancets Market Forecast, by End User 12.13.1. Hospitals & Clinics 12.13.2. Home Care Settings 12.13.3. Other End Users 12.14. Germany Lancets Market Forecast, by Type 12.14.1. Safety Lancets 12.14.1.1. Push-Button Lancets 12.14.1.2. Pressure-Activated Lancets 12.14.1.3. Side-Button Lancets 12.14.2. Personal Lancets 12.15. U.K. Lancets Market Forecast, by Application 12.15.1. Glucose Testing 12.15.2. Hemoglobin Testing 12.15.3. Coagulation Testing 12.15.4. Other Applications 12.16. U.K. Lancets Market Forecast, by End User 12.16.1. Hospitals & Clinics 12.16.2. Home Care Settings 12.16.3. Other End Users 12.17. U.K. Lancets Market Forecast, by Type 12.17.1. Safety Lancets 12.17.1.1. Push-Button Lancets 12.17.1.2. Pressure-Activated Lancets 12.17.1.3. Side-Button Lancets 12.17.2. Personal Lancets 12.18. France Lancets Market Forecast, by Application 12.18.1. Glucose Testing 12.18.2. Hemoglobin Testing 12.18.3. Coagulation Testing 12.18.4. Other Applications 12.19. France Lancets Market Forecast, by End User 12.19.1. Hospitals & Clinics 12.19.2. Home Care Settings 12.19.3. Other End Users 12.20. France Lancets Market Forecast, by Type 12.20.1. Safety Lancets 12.20.1.1. Push-Button Lancets 12.20.1.2. Pressure-Activated Lancets 12.20.1.3. Side-Button Lancets 12.20.2. Personal Lancets 12.21. Italy Lancets Market Forecast, by Application 12.21.1. Glucose Testing 12.21.2. Hemoglobin Testing 12.21.3. Coagulation Testing 12.21.4. Other Applications 12.22. Italy Lancets Market Forecast, by End User 12.22.1. Hospitals & Clinics 12.22.2. Home Care Settings 12.22.3. Other End Users 12.23. Italy Lancets Market Forecast, by Type 12.23.1. Safety Lancets 12.23.1.1. Push-Button Lancets 12.23.1.2. Pressure-Activated Lancets 12.23.1.3. Side-Button Lancets 12.23.2. Personal Lancets 12.24. Spain Lancets Market Forecast, by Application 12.24.1. Glucose Testing 12.24.2. Hemoglobin Testing 12.24.3. Coagulation Testing 12.24.4. Other Applications 12.25. Spain Lancets Market Forecast, by End User 12.26. Spain Lancets Market Forecast, by Type 12.26.1. Safety Lancets 12.26.1.1. Push-Button Lancets 12.26.1.2. Pressure-Activated Lancets 12.26.1.3. Side-Button Lancets 12.26.2. Personal Lancets 12.27. Rest of Europe Lancets Market Forecast, by Application 12.27.1. Glucose Testing 12.27.2. Hemoglobin Testing 12.27.3. Coagulation Testing 12.27.4. Other Applications 12.28. Rest of Europe Lancets Market Forecast, by End User 12.28.1. Hospitals & Clinics 12.28.2. Home Care Settings 12.28.3. Other End Users 12.29. Rest Of Europe Lancets Market Forecast, by Type 12.29.1. Safety Lancets 12.29.1.1. Push-Button Lancets 12.29.1.2. Pressure-Activated Lancets 12.29.1.3. Side-Button Lancets 12.29.2. Personal Lancets 12.30. Europe Lancets Market Attractiveness Analysis 12.30.1. By Application 12.30.2. By End User 12.30.3. By Type 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Lancets Market Analysis 13.1. Key Findings 13.2. Asia Pacific Lancets Market Overview 13.3. Asia Pacific Lancets Market Value Share Analysis, by Application 13.4. Asia Pacific Lancets Market Forecast, by Application 13.4.1. Glucose Testing 13.4.2. Hemoglobin Testing 13.4.3. Coagulation Testing 13.4.4. Other Applications 13.5. Asia Pacific Lancets Market Value Share Analysis, by End User 13.6. Asia Pacific Lancets Market Forecast, by End User 13.6.1. Hospitals & Clinics 13.6.2. Home Care Settings 13.6.3. Other End Users 13.7. Asia Pacific Lancets Market Value Share Analysis, by Type 13.8. Asia Pacific Lancets Market Forecast, by Type 13.8.1. Safety Lancets 13.8.1.1. Push-Button Lancets 13.8.1.2. Pressure-Activated Lancets 13.8.1.3. Side-Button Lancets 13.8.2. Personal Lancets 13.9. Asia Pacific Lancets Market Value Share Analysis, by Country 13.10. Asia Pacific Lancets Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Lancets Market Analysis, by Country 13.12. China Lancets Market Forecast, by Application 13.12.1. Glucose Testing 13.12.2. Hemoglobin Testing 13.12.3. Coagulation Testing 13.12.4. Other Applications 13.13. China Lancets Market Forecast, by End User 13.13.1. Hospitals & Clinics 13.13.2. Home Care Settings 13.13.3. Other End Users 13.14. China Lancets Market Forecast, by Type 13.14.1. Safety Lancets 13.14.1.1. Push-Button Lancets 13.14.1.2. Pressure-Activated Lancets 13.14.1.3. Side-Button Lancets 13.14.2. Personal Lancets 13.15. India Lancets Market Forecast, by Application 13.15.1. Glucose Testing 13.15.2. Hemoglobin Testing 13.15.3. Coagulation Testing 13.15.4. Other Applications 13.16. India Lancets Market Forecast, by End User 13.16.1. Hospitals & Clinics 13.16.2. Home Care Settings 13.16.3. Other End Users 13.17. India Lancets Market Forecast, by Type 13.17.1. Safety Lancets 13.17.1.1. Push-Button Lancets 13.17.1.2. Pressure-Activated Lancets 13.17.1.3. Side-Button Lancets 13.17.2. Personal Lancets 13.18. Japan Lancets Market Forecast, by Application 13.18.1. Glucose Testing 13.18.2. Hemoglobin Testing 13.18.3. Coagulation Testing 13.18.4. Other Applications 13.19. Japan Lancets Market Forecast, by End User 13.19.1. Hospitals & Clinics 13.19.2. Home Care Settings 13.19.3. Other End Users 13.20. Japan Lancets Market Forecast, by Type 13.20.1. Safety Lancets 13.20.1.1. Push-Button Lancets 13.20.1.2. Pressure-Activated Lancets 13.20.1.3. Side-Button Lancets 13.20.2. Personal Lancets 13.21. ASEAN Lancets Market Forecast, by Application 13.21.1. Glucose Testing 13.21.2. Hemoglobin Testing 13.21.3. Coagulation Testing 13.21.4. Other Applications 13.22. ASEAN Lancets Market Forecast, by End User 13.22.1. Hospitals & Clinics 13.22.2. Home Care Settings 13.22.3. Other End Users 13.23. ASEAN Lancets Market Forecast, by Type 13.23.1. Safety Lancets 13.23.1.1. Push-Button Lancets 13.23.1.2. Pressure-Activated Lancets 13.23.1.3. Side-Button Lancets 13.23.2. Personal Lancets 13.24. Rest of Asia Pacific Lancets Market Forecast, by Application 13.24.1. Glucose Testing 13.24.2. Hemoglobin Testing 13.24.3. Coagulation Testing 13.24.4. Other Applications 13.25. Rest of Asia Pacific Lancets Market Forecast, by End User 13.25.1. Hospitals & Clinics 13.25.2. Home Care Settings 13.25.3. Other End Users 13.26. Rest of Asia Pacific Lancets Market Forecast, by Type 13.26.1. Safety Lancets 13.26.1.1. Push-Button Lancets 13.26.1.2. Pressure-Activated Lancets 13.26.1.3. Side-Button Lancets 13.26.2. Personal Lancets 13.27. Asia Pacific Lancets Market Attractiveness Analysis 13.27.1. By Application 13.27.2. By End User 13.27.3. By Type 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Lancets Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Lancets Market Overview 14.3. Middle East & Africa Lancets Market Value Share Analysis, by Application 14.4. Middle East & Africa Lancets Market Forecast, by Application 14.4.1. Glucose Testing 14.4.2. Hemoglobin Testing 14.4.3. Coagulation Testing 14.4.4. Other Applications 14.5. Middle East & Africa Lancets Market Value Share Analysis, by End User 14.6. Middle East & Africa Lancets Market Forecast, by End User 14.6.1. Hospitals & Clinics 14.6.2. Home Care Settings 14.6.3. Other End Users 14.7. Middle East & Africa Lancets Market Value Share Analysis, by Type 14.8. Middle East & Africa Lancets Market Forecast, by Type 14.8.1. Safety Lancets 14.8.1.1. Push-Button Lancets 14.8.1.2. Pressure-Activated Lancets 14.8.1.3. Side-Button Lancets 14.8.2. Personal Lancets 14.9. Middle East & Africa Lancets Market Value Share Analysis, by Country 14.10. Middle East & Africa Lancets Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Lancets Market Analysis, by Country 14.12. GCC Lancets Market Forecast, by Application 14.12.1. Glucose Testing 14.12.2. Hemoglobin Testing 14.12.3. Coagulation Testing 14.12.4. Other Applications 14.13. GCC Lancets Market Forecast, by End User 14.13.1. Hospitals & Clinics 14.13.2. Home Care Settings 14.13.3. Other End Users 14.14. GCC Lancets Market Forecast, by Type 14.14.1. Safety Lancets 14.14.1.1. Push-Button Lancets 14.14.1.2. Pressure-Activated Lancets 14.14.1.3. Side-Button Lancets 14.14.2. Personal Lancets 14.15. South Africa Lancets Market Forecast, by Application 14.15.1. Glucose Testing 14.15.2. Hemoglobin Testing 14.15.3. Coagulation Testing 14.15.4. Other Applications 14.16. South Africa Lancets Market Forecast, by End User 14.16.1. Hospitals & Clinics 14.16.2. Home Care Settings 14.16.3. Other End Users 14.17. South Africa Lancets Market Forecast, by Type 14.17.1. Safety Lancets 14.17.1.1. Push-Button Lancets 14.17.1.2. Pressure-Activated Lancets 14.17.1.3. Side-Button Lancets 14.17.2. Personal Lancets 14.18. Rest of Middle East & Africa Lancets Market Forecast, by Application 14.18.1. Glucose Testing 14.18.2. Hemoglobin Testing 14.18.3. Coagulation Testing 14.18.4. Other Applications 14.19. Rest of Middle East & Africa Lancets Market Forecast, by End User 14.19.1. Hospitals & Clinics 14.19.2. Home Care Settings 14.19.3. Other End Users 14.20. Rest of Middle East & Africa Lancets Market Forecast, by Type 14.20.1. Safety Lancets 14.20.1.1. Push-Button Lancets 14.20.1.2. Pressure-Activated Lancets 14.20.1.3. Side-Button Lancets 14.20.2. Personal Lancets 14.21. Middle East & Africa Lancets Market Attractiveness Analysis 14.21.1. By Application 14.21.2. By End User 14.21.3. By Type 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Lancets Market Analysis 15.1. Key Findings 15.2. South America Lancets Market Overview 15.3. South America Lancets Market Value Share Analysis, by Application 15.4. South America Lancets Market Forecast, by Application 15.4.1. Glucose Testing 15.4.2. Hemoglobin Testing 15.4.3. Coagulation Testing 15.4.4. Other Applications 15.5. South America Lancets Market Value Share Analysis, by End User 15.6. South America Lancets Market Forecast, by End User 15.6.1. Hospitals & Clinics 15.6.2. Home Care Settings 15.6.3. Other End Users 15.7. South America Lancets Market Value Share Analysis, by Type 15.8. South America Lancets Market Forecast, by Type 15.8.1. Safety Lancets 15.8.1.1. Push-Button Lancets 15.8.1.2. Pressure-Activated Lancets 15.8.1.3. Side-Button Lancets 15.8.2. Personal Lancets 15.9. South America Lancets Market Value Share Analysis, by Country 15.10. South America Lancets Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Lancets Market Analysis, by Country 15.12. Brazil Lancets Market Forecast, by Application 15.12.1. Glucose Testing 15.12.2. Hemoglobin Testing 15.12.3. Coagulation Testing 15.12.4. Other Applications 15.13. Brazil Lancets Market Forecast, by End User 15.13.1. Hospitals & Clinics 15.13.2. Home Care Settings 15.13.3. Other End Users 15.14. Brazil Lancets Market Forecast, by Type 15.14.1. Safety Lancets 15.14.1.1. Push-Button Lancets 15.14.1.2. Pressure-Activated Lancets 15.14.1.3. Side-Button Lancets 15.14.2. Personal Lancets 15.15. Mexico Lancets Market Forecast, by Application 15.15.1. Glucose Testing 15.15.2. Hemoglobin Testing 15.15.3. Coagulation Testing 15.15.4. Other Applications 15.16. Mexico Lancets Market Forecast, by End User 15.16.1. Hospitals & Clinics 15.16.2. Home Care Settings 15.16.3. Other End Users 15.17. Mexico Lancets Market Forecast, by Type 15.17.1. Safety Lancets 15.17.1.1. Push-Button Lancets 15.17.1.2. Pressure-Activated Lancets 15.17.1.3. Side-Button Lancets 15.17.2. Personal Lancets 15.18. Rest of South America Lancets Market Forecast, by Application 15.18.1. Glucose Testing 15.18.2. Hemoglobin Testing 15.18.3. Coagulation Testing 15.18.4. Other Applications 15.19. Rest of South America Lancets Market Forecast, by End User 15.19.1. Hospitals & Clinics 15.19.2. Home Care Settings 15.19.3. Other End Users 15.20. Rest of South America Lancets Market Forecast, by Type 15.20.1. Safety Lancets 15.20.1.1. Push-Button Lancets 15.20.1.2. Pressure-Activated Lancets 15.20.1.3. Side-Button Lancets 15.20.2. Personal Lancets 15.21. South America Lancets Market Attractiveness Analysis 15.21.1. By Application 15.21.2. By End User 15.21.3. By Type 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Becton, Dickinson and Company 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Company Footprint 16.3.2. Roche Diagnostics 16.3.3. Ypsomed 16.3.4. B. Braun Melsungen 16.3.5. Terumo Corporation 16.3.6. Owen Mumford 16.3.7. HTL-Strefa S.A 16.3.8. Arkray 16.3.9. Sarstedt 16.3.10. Sterilance Medical (Suzhou) 16.3.11. Medline Industries 16.3.12. Intrinsyk 16.3.13. I-SENS 16.3.14. Nipro 16.3.15. Omron 16.3.16. Infopia 16.3.17. Terumo Corporation 16.3.18. Bayer AG 16.3.19. Abbott Laboratories 16.3.20. F. Hoffmann-La Roche Ltd 16.3.21. Greiner Bio-One International GmbH 16.3.22. Improve Medical Instruments Co. Ltd (US) 16.3.23. Lifescan 16.3.24. AgaMatrix 16.3.25. Smiths Medical 16.3.26. SANNUO 16.3.27. Yicheng 16.3.28. Yuwell 16.3.29. Edan 16.3.30. Narang Medical 17. Primary Key Insights

About This Report

Report ID31935
Category Healthcare
Published DateJuly 2019
Updated DateMarch 2021
Contact Us